Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole...
Many of the successful, FDA-approved drugs commonly used in cancer care were developed at small biotech or pharma companies—so what role do the "big fish" play?
Support for federal research funding for cancer is not about politics. It's about people. There is no one in our society—liberal, conservative, libertarian, or just don’t care—who isn’t touched in some way by...